The Annals
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     


The Annals of Pharmacotherapy: Vol. 37, No. 11, pp. 1730. DOI 10.1345/aph.1D189
© 2003 Harvey Whitney Books Company.
This Article
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Andrès, E.
Right arrow Articles by Abdelghani, M. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andrès, E.
Right arrow Articles by Abdelghani, M. B.

Vitamin B12 deficiency associated with chronic acid suppression therapy

Emmanuel Andrès, MD

Professor of Internal Medicine Université Louis Pasteur Strasbourg, France Clinical Specialist Department of Internal Medicine, Diabetes and Metabolic Disorders Clinique Médicale B Hôpitaux Universitaires de Strasbourg 1 Place de l'Hôpital 67 091 Strasbourg cedex, France FAX 33-3-88-11-62-62 emmanuel.andres{at}chru-strasbourg.fr

Esther Noel, MD

Assistant of Internal Medicine Université Louis Pasteur Clinical Specialist Department of Internal Medicine, Diabetes and Metabolic Disorders Hôpitaux Universitaires de Strasbourg

Meher Ben Abdelghani, MD

Assistant of Internal Medicine Université Louis Pasteur Clinical Specialist Department of Internal Medicine, Diabetes and Metabolic Disorders Hôpitaux Universitaires de Strasbourg

Published Online, September 18, 2003. www.theannals.com, DOI 10.1345/aph.1D189


TO THE EDITOR: We read with interest the articles by Force et al.1 and Ruscin et al.2 about vitamin B12 (B12) deficiency associated with chronic acid suppression therapy. To date, only case reports or epidemiologic studies have reported patients with decreased B12 levels or true B12 deficiency associated with acid suppression therapy. Here, we report 6 new cases extracted from a cohort of 160 patients with established B12 deficiencies.3 Use of the Naranjo probability scale indicated a probable relationship in these cases.4

Case Reports. The median age of the patients was 70 years (range 49-76); the male/female ratio was 4/2. The mean duration of the acid-suppressive drug administration (omeprazole [n = 3], ranitidine [n = 1], cimetidine [n = 1], sodium bicarbonate [n = 1]) was 7.1 years (range 5.5-9). Clinical features included peripheral neuropathy in 1 patient. Blood count abnormalities included mild anemia (hemoglobin [Hb] <10 g/dL) in 2 patients. The mean ± SD Hb level was 10.9 ± 2.4 g/dL (range 8-12.8) and the mean erythrocyte cell volume was 96 ± 8 fL (range 87-102). The mean serum B12 (normal >200 pg/mL) and total homocysteine levels (normal >13 µmol/L) were 118 ± 37 pg/mL (range 70-162) and 13 ± 2.3 µmol/L (range 11-20), respectively.

All patients had normal serum folate and creatinine levels; none had antiintrinsic factor antiparietal cell antibodies. All patients had normal Schilling's test results (Dicopac test, Amersham, Birmingham, UK). No patient had a nutritional B12 deficiency. One patient with anemia was successfully treated with oral crystalline cyanocobalamin 2000 µg/wk despite continuous administration of an acid-suppressive drug. Other patients had been treated with intramuscular cyanocobalamin (n = 4). In all cases, correction of the serum B12 levels and blood count abnormalities occurred during the first 6 months of treatment.

Discussion. Acid-suppressive drugs represent about 4% of the etiologies in this population, and are undoubtedly the principal causative drugs (with metformin) of B12 deficiency in adults.3,5 The B12 deficiency related to long-term acid suppression therapy is mild ("subtle cobalamin deficiency"),5 with no or only mild clinical and hematologic abnormalities.2,3 As several authors have previously reported,1,2 our data suggest that the principal mechanism of B12 deficiency related to long-term acid suppression therapy is food-cobalamin malabsorption (FCM). This syndrome is characterized by the inability to release B12 from food or its binding protein.3,5 Thus, patients have low serum B12 levels, normal Schilling's test results, and commonly hypochlorhydria.

The partial nature of this form of malabsorption produces a more slowly progressing depletion of B12 than does the more complete malabsorption engendered by disruption of intrinsic factor-mediated absorption. This partial malabsorption also explains why subtle cobalamin deficiency is often associated with FCM.5 This mechanism of partial FCM may explain the potential efficacy of oral crystalline cyanocobalamin.3,5 In our opinion, acid-suppressive drugs may often be continued with appropriate B12 supplementation.

Physicians should always reassess patients who are taking acid-suppressive drugs for a long time for vitamin B12 status because of potentially irreversible neurologic complications.

References

  1. Force RW, Meeker AD, Cady PS, Culbertson VL, Force WS, Kelley CM. Increased vitamin B12 requirement associated with chronic acid suppression therapy. Ann Pharmacother 2003;37: 490-3. DOI 10.1345/aph.1C037[Abstract/Free Full Text]
  2. Ruscin JM, Page RL 2nd, Valuck RJ. Vitamin B12 deficiency associated with histamine2-receptor antagonists and a proton-pump inhibitor. Ann Pharmacother 2002;36: 812-6. DOI 10.1345/aph.10325[Abstract]
  3. Andrès E, Goichot B, Schlienger JL. Food-cobalamin malabsorption: a usual cause of vitamin B12 deficiency.Arch Intern Med 2000;160:2061-2.[Free Full Text]
  4. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions.Clin Pharmacol Ther 1981;30:239-45.[Medline]
  5. Andrès E, Noel E, Kaltenbach G, Perrin AE, Vinzio S, Goichot B, et al. [Vitamin B12 deficiency with normal Schilling test or non-dissociation of vitamin B12 and its carrier proteins in elderly patients. A study of 60 patients] French. Rev Med Interne 2003;24:218-23.[Medline]



This article has been cited by other articles:


Home page
QJMHome page
N. Dali-Youcef and E. Andres
An update on cobalamin deficiency in adults
QJM, January 1, 2009; 102(1): 17 - 28.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
E. Andres, N. H. Loukili, E. Noel, G. Kaltenbach, M. B. Abdelgheni, A. E. Perrin, M. Noblet-Dick, F. Maloisel, J.-L. Schlienger, and J.-F. Blickle
Vitamin B12 (cobalamin) deficiency in elderly patients
Can. Med. Assoc. J., August 3, 2004; 171(3): 251 - 259.
[Abstract] [Full Text] [PDF]


This Article
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Andrès, E.
Right arrow Articles by Abdelghani, M. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andrès, E.
Right arrow Articles by Abdelghani, M. B.


homecopy help contact us subscription past issues search current issue